Back to results
US 2022/0175876 A1Published application
Angio-3 for treatment of retinal angiogenic diseases
AssigneesSingapore Health Services Pte Ltd, National University of Singapore
InventorsMichael BELKIN, BARATH Amutha Veluchamy, LAKSHMINARAYANAN Rajamani, Manjunatha R. KINI, RUOWEN Ge, Tien Yin WONG, Gemmy Chui Ming CHEUNG
Life of this patent
Estimating the term…
Abstract
This disclosure provides methods of a method of treating a retinal angiogenic disease in a subject comprising administering an effective amount of an Angio-3 peptide.
Claims14
-24. (canceled)
A method of treating a retinal angiogenic disease in a subject comprising:
- (a) selecting a subject with retinal angiogenic disease not responsive to anti-VEGF therapy;
- and
- (b) administering to the subject a composition comprising a peptide consisting of the sequence Thr Pro His Thr His Gin Xaa Thr Pro Glu (SEQ ID NO:4) wherein administration treats the retinal angiogenic disease in the subject.
Dependencies are inferred from the claim text.